AFC-HD AMS Life Science Co., Ltd. provided earnings guidance for the year ending August 2023. For the period, the company expects net sales of ¥24,741 million, Operating profit of ¥1,481 million, and Profit attributable to owners of the parent of ¥687 million or ¥48.82 basic per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
911 JPY | -0.87% | -0.98% | +13.88% |
1st Jan change | Capi. | |
---|---|---|
+13.88% | 79.91M | |
+13.33% | 8.13B | |
+9.35% | 7.91B | |
-19.26% | 4.76B | |
-8.54% | 3.63B | |
-20.61% | 3.16B | |
-12.55% | 1.2B | |
-26.47% | 1.12B | |
-7.63% | 892M | |
-17.95% | 838M |
- Stock Market
- Equities
- 2927 Stock
- News AFC-HD AMS Life Science Co., Ltd.
- AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023